Commentary

Dr. John Bates

Anyone for Tea and Sympathy with Beleaguered HFT Firms?

Guest columnist John Bates wonders if anyone feels bad for the high-frequency trading firms that are now facing lawsuits, sluggish markets and regulators.

Traders Poll

Do you expect more SEC investigations into order routing or handling?



Advertisement

Free Site Registration

Latest News

Goldman Sachs Looks At Purchasing ETF Provider

– White glove bulge bracket broker Goldman Sachs appears like it could be readying a move into the exchange traded fund space. And soon.

Wells Fargo Shuts Dark Pool on Volume Drought

– Plagued by light investor demand and competition from other major alternative trading venues such as Crossfinder and Liquidnet, Wells Fargo the company announced late last week it was closing the pool.

TRADERS ON THE MOVE: BCS Gets New CEO, Rubenfeld Lands at Financial Services

– Russian broker-dealer BCS has named a new chief executive officer, a Credit Suisse partner has hired a one-time Traders columnist and alternative broker Venovate brought on a new board member.

Over-the-Counter U.S. Stock Trading Resumes After Friday Malfunction

– Trading of U.S. stocks that change hands in over-the-counter transactions has resumed after it was halted for about two hours on Friday following a malfunction at OTC Markets Group Inc.

What Dark Pool Problems and Spreadsheet Errors Have in Common

– So what do dark pools, the bond market and spreadsheets have in common? Columnist Matt Levine takes a look at all in today's guest commentary.

BlackRock Brings New iShares Emerging Mart ETF via BATS

– BlackRock's iShares group is bringing its second exchange-traded fund in as many days. However, this new emerging markets ETF is listed on BATS.

Bloomberg Tradebook Launches Electronic RFQ Platform for ETFs

– Agency broker Bloomberg wants to bring the block trade from cash equities to the exchange traded fund market.

Big Banks Grab 53 Percent of FX Market Share, Can Climb Higher

– Big banks are getting bigger - in the foreign exchange trading markets. But how big?

More Stories

Highlights from the Current Issue

Palo Alto FX Trader Looks for Volatility

Daniel Lucas of Merk Investments is leading the foreign exchange charge in the buyside firm’s offices in the heart of Silicon Valley.

Why Trading Floors Are Shrinking

A wave of ground-breaking innovation and lower volumes has forced floor traders to face a new reality: a smaller, more intimate trading floor.

ALGO UPDATE: Pragma Offers Spot FX Currency Algos

The $5.4 trillion currency market is going electronic and Pragma is getting in the game now with its own algorithms targeting the $2 trillion spot market. The service bureau provider will start offering a variety of algorithms specifically for FX, ranging from simple TWAP to more complex liquidity seekers that minimize market impact.

In the CARDS - Is Finra's Data System Protecting Brokers or Investors?

Guest columnist Robert Stowksy reviews how FINRA's use of broker data to protect investors is under attack and asks the question, "Are they protecting investors or covering for bad brokers?"

TRADERS ON THE MOVE: ConvergEx Hires a Trio of Pros; Farrington Flies With Eagle

Agency-only broker and technology firm ConvergEx has hired a trio of market professionals to help it expand it's global reach while Eagle Investment Systems brought on Greg Farrington as it new head of sales. Bulge bracket broker UBS has hired Pierre Vermaak for its newly formed FRC team.

Reputational Risk RIP

Today, a $5 billion fine is the cost of doing business. How can any Wall Street firm take risk seriously?

BOOK REVIEW: 'Flash Boys' Burns HFT

Traders' reviews the controversial Michael Lewis tome 'Flash Boys' and how it has changed the way Americans think about high-frequency trading "if they even thought about it all" and its impact that may be seen in new regulations.

The Long Compliance Race

In an industry dominated by speed, where short-term success is dependent on decisions made faster than the blink of an eye, guest commentator Mark Knoll said that getting traders to focus on the long-term impact of regulatory changes is like trying to get a world class sprinter to think like a marathon runner.

CLEARING: CME's Sprague Warns About Failure to Settle Clearing Impasse

Traders spoke to Suzanne Sprague, executive director of collateral and risk for CME Clearing about the impasse, how to resolve it, and what it means for the clearing market.

HFT Hype Should Give Way to Serious Market Discussion, Experts Say

With the immediate furor over Michael Lewis's book, Flash Boys, finally dying down, many market players are hoping the receding hype gives way to a discussion of the real problems and possible solutions to some of the issues the book brought up - namely market structure.

ALGO UPDATE: Neonet Readies Algos for Europe; U.S. to Follow

Swedish agency-broker Neonet has a simple business strategy – offer its algorithms and electronic trading solutions first to its native European equity trading clients, and then cross the Atlantic and enter the U.S. equity markets.

Watch the Fiscal Rocks

Modern Network's Tim Quast discusses Michael Lewis's cage-rattling bestseller about high-speed trading, "Flash Boys," and how it left one thing out. Quast notes Lewis didn't say why exchanges pay fast traders. The answer spotlights the importance of getting right whatever corrective market-structure measures may come.

Current Issue

Sponsored Series

Advertisement

Advertisement

Current Issue

Traders Magazine

The stock dealers and institutional traders complete interactive news and information service

Advertisement

NYSE Euronext Announces Trading Volumes for November 2012

NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for November 20121. Global derivatives average daily volume (“ADV”) of 8.1 million contracts in November 2012 decreased 2.5% compared to November 2011, but increased 12.2% from October 2012. Trading volumes in European and U.S. equities, declined year-over-year but U.S equities improved from October 2012 levels.

Highlights

  • NYSE Euronext global derivatives ADV in November 2012 of 8.1 million contracts decreased 2.5% compared to November 2011 but increased 12.2% from October 2012 levels.
  • NYSE Euronext European derivatives products ADV in November 2012 of 4.0 million contracts increased 0.2% compared to November 2011, and increased 26.8% from October 2012 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 24.6% compared to November 2011 but increased 2.3% from October 2012.
  • NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.1 million contracts in November 2012 decreased 4.2% compared to November 2011 levels, but increased by 0.7% from October 2012 levels. NYSE Euronext’s U.S. options exchanges accounted for 28.1% of total U.S. consolidated equity options trading in November 2012, unchanged from the prior month and down only slightly from last month’s record high.
  • NYSE Liffe U.S. ADV of approximately 51,500 contracts decreased from 88,500 contracts in November 2011, but increased from 43,700 contracts in October 2012.
  • NYSE Euronext European cash products ADV of 1.2 million transactions in November 2012 decreased 30.0% compared to November 2011 and decreased 8.5% compared to October 2012.
  • NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 1.6 billion shares in November 2012 decreased 24.8% compared to November 2011 but increased 3.2% compared to October 2012. NYSE Euronext’s Tape A matched market share in November 2012 was 31.7%, down from 34.1% in November 2011, but up from 30.6% in October 2012.

Derivatives Trading

European Derivatives

  • NYSE Euronext European derivatives products ADV in November 2012 was 4.0 million futures and options contracts, an increase of 0.2% from November 2011 and an increase of 26.8% from October 2012.
  • The 4.0 million in European derivatives futures and options contracts ADV in November 2012 consisted of 2.4 million contracts executed through our full-service LIFFE CONNECT trading platform and 1.6 million contracts, or 40.9%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV decreased 24.6% compared to November 2011, but increased 2.3% from October 2012.
  • Year-to-date, European derivatives products ADV of 3.7 million contracts was 18.0% below prior year levels. The 3.7 million in futures and options contracts ADV year-to-date consisted of 3.6 million contracts executed through LIFFE CONNECT trading platform and 1.1 million contracts, or 30.0%, executed through Bclear.
  • Total fixed income products ADV of 1.6 million contracts in November 2012 decreased 25.9% from November 2011 but increased 3.9% from October 2012. Year-to-date, total fixed income products ADV of 1.8 million contracts was 24.1% below prior year levels.
  • Total equity products (including Bclear) ADV of 2.3 million contracts in November 2012 increased 30.8% compared to November 2011 and increased 53.2% from October 2012. The 2.3 million contracts in equity products ADV consisted of 1.9 million contracts in individual equity products ADV and 0.4 million contracts in equity index products ADV. The 1.9 million contracts in individual equity products ADV consisted of 1.5 million in futures contracts, which represented a 115.3% increase compared to November 2011 and 0.4 million in options contracts, which represented a 31.8% decrease compared to November 2011. Year-to-date, total equity products ADV of 1.9 million contracts were 12.5% below prior year levels.
  • Total commodities products ADV of 86,000 contracts in November 2012 increased 26.2% compared to November 2011, but decreased 18.5% compared to October 2012. Year-to-date, total commodities product ADV of 89,000 contracts was 8.3% above prior year levels.

U.S. Derivatives

  • NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.1 million contracts in November 2012 decreased 4.2% compared to November 2011, but increased 0.7% compared to October 2012. Year-to-date, U.S. equity options ADV of 3.9 million contracts was 12.5% below prior year levels.
  • Total U.S. consolidated equity options ADV decreased 4.2% to 14.5 million contracts in November 2012 compared to November 2011 but increased 2.1% compared to October 2012. Year-to-date, U.S. consolidated equity options ADV of 14.8 million contracts was 13.1% below prior year levels.
  • NYSE Euronext’s U.S. options exchanges accounted for 28.1% of the total U.S. consolidated equity options trading in November 2012, in line with 28.1% in November 2011, but down slightly from a record 28.5% in October 2012. NYSE Euronext was the #1 options exchange in terms of market share for the second consecutive month.
  • NYSE Liffe U.S. ADV of approximately 51,500 contracts decreased from 88,500 contracts in November 2011, but increased from 43,700 contracts in October 2012. Year-to-date, U.S. futures and futures options ADV of 72,800 contracts was 9.5% below prior year levels.

Cash Trading

European Cash

  • NYSE Euronext European cash products ADV of 1.2 million transactions in November 2012 decreased 30.0% compared to November 2011 and decreased 8.5% compared to October 2012.
  • Year-to-date, European cash products ADV of 1.5 million transactions was 15.4% below prior year levels.

U.S. Cash

  • NYSE Euronext U.S. cash products handled ADV in November 2012 decreased 24.8% to 1.6 billion shares compared to November 2011 but increased 3.2% from October 2012.
  • Year-to-date, U.S. cash products handled ADV was 1.7 billion shares, down 27.0% from prior year levels.
  • NYSE Euronext’s Tape A matched market share in November 2012 was 31.7%, down from 34.1% in November 2011, but up from 30.6% in October 2012.

Exchange Traded Funds

  • NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 209 million shares in November 2012 decreased 34.9% compared to November 2011, but increased 9.8% compared to October 2012.
  • Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of 212 million shares was 35.8% below prior year levels.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets - the New York Stock Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca - represent one-third of the world’s equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index. For more information, please visit:http://www.nyx.com.

Please follow us at:

Exchanges Blog

Facebook

LinkedIn

Twitter

Disclaimer and Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's 2011 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

1 All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

NYSE Euronext

Monthly Volume Summary

Average Daily VolumeTotal VolumeAverage Daily VolumeTotal Volume

% Chg vs.

% Chg vs.

(Unaudited; contracts in thousands)

Nov-12Nov-11% ChgNov-12Nov-11% Chg

YTD 2012

YTD 2011YTD 2012

YTD 2011

Number of Trading Days - European Cash 22 22 22 22 237 237
Number of Trading Days - European Derivatives 22 22 22 22 238 238
Number of Trading Days - U.S. Markets 21 21 21 21 230 230
European Derivatives Products3,9833,9740.2%87,61687,4320.2%3,737-18.0%889,477-17.4%
of which Bclear 1,630 855 90.6% 35,857 18,811 90.6% 1,103 -2.5% 262,605 -1.7%
Total Fixed Income Products1,5822,136-25.9%34,80346,998-25.9%1,768-24.1%420,750-23.5%
Short Term Interest Rate Products 1,376 1,963 -29.9% 30,267 43,195 -29.9% 1,613 -26.2% 383,910 -25.6%
Medium and Long Term Interest Rate Products 1 206 173 19.3% 4,537 3,803 19.3% 155 7.6% 36,840 8.5%
Total Equity Products 22,3141,77030.8%50,91438,93030.8%1,881-12.5%447,634-11.7%
Individual Equity Products 1,884 1,240 52.0% 41,457 27,275 52.0% 1,407 -10.0% 334,756 -9.3%
Futures 1,521 706 115.3% 33,454 15,539 115.3% 963 -0.4% 229,301 0.4%
Options 364 533 -31.8% 8,003 11,737 -31.8% 443 -25.6% 105,456 -25.0%
Equity Index Products 430 530 -18.9% 9,457 11,654 -18.9% 474 -19.0% 112,878 -18.3%
of which Bclear 1,630 855 90.6% 35,857 18,811 90.6% 1,103 -2.5% 262,605 -1.7%
Individual Equity Products 1,556 787 97.7% 34,236 17,320 97.7% 1,030 -2.1% 245,169 -1.3%
Futures 1,494 681 119.3% 32,872 14,987 119.3% 940 -1.1% 223,727 -0.2%
Options 62 106 -41.5% 1,365 2,333 -41.5% 90 -11.9% 21,443 -11.2%
Equity Index Products 74 68 8.8% 1,621 1,490 8.8% 73 -8.0% 17,435 -7.3%
Commodity Products866826.2%1,8981,50426.2%898.3%21,0939.2%
U.S. Derivatives Products
Equity Options 3
NYSE Euronext Options Contracts 4,068 4,244 -4.2% 85,423 89,127 -4.2% 3,893 -12.5% 895,374 -12.9%
Total Consolidated Options Contracts 14,488 15,119 -4.2% 304,256 317,497 -4.2% 14,767 -13.1% 3,396,328 -13.5%
NYSE Group Share of Total 28.1% 28.1% 28.1% 28.1% 26.4% 0.2% 26.4% 0.2%
NYSE Liffe U.S.
Futures and Futures Options Volume* 51.5 88.5 -41.8% 1,133 1,947 -41.8% 72.8 -9.5% 17,316.9 -9.1%
European Cash Products (trades in thousands)1,1701,671-30.0%25,73936,756-30.0%1,476-15.4%349,716-15.0%
Equities 1,122 1,602 -29.9% 24,693 35,243 -29.9% 1,426 -14.9% 337,862 -14.6%
Exchange-Traded Funds 12 22 -43.3% 274 483 -43.3% 13 -35.7% 3,191 -35.5%
Structured Products 29 42 -30.1% 644 922 -30.1% 31 -26.1% 7,426 -25.8%
Bonds 6 5 18.1% 127 108 18.1% 5 4.6% 1,236 5.0%
U.S. Cash Products (shares in millions) 51,5852,108-24.8%33,28444,272-24.8%1,699-27.0%390,714-27.3%
NYSE Listed (Tape A) Issues 4
Handled Volume 5 1,132 1,466 -22.8% 23,772 30,790 -22.8% 1,216 -25.7% 279,573 -26.1%
Matched Volume 6 1,086 1,391 -22.0% 22,804 29,219 -22.0% 1,154 -25.6% 265,422 -25.9%
Total NYSE Listed Consolidated Volume 3,421 4,083 -16.2% 71,832 85,749 -16.2% 3,685 -17.0% 847,585 -17.3%

Share of Total Consolidated Volume

Handled Volume 5 33.1% 35.9% -2.8% 33.1% 35.9% -2.8% 33.0% -3.9% 33.0% -3.9%
Matched Volume 6 31.7% 34.1% -2.4% 31.7% 34.1% -2.4% 31.3% -3.6% 31.3% -3.6%
NYSE Arca, MKT and Regional (Tape B) Listed Issues
Handled Volume 5 235 368 -36.2% 4,936 7,738 -36.2% 250 -35.8% 57,456 -36.1%
Matched Volume 6 217 333 -34.7% 4,564 6,988 -34.7% 226 -35.5% 51,956 -35.8%
Total NYSE Arca & MKT Listed Consolidated Volume 1,010 1,422 -29.0% 21,213 29,868 -29.0% 1,063 -29.2% 244,429 -29.5%
Share of Total Consolidated Volume
Handled Volume 5 23.3% 25.9% -2.6% 23.3% 25.9% -2.6% 23.5% -2.4% 23.5% -2.4%
Matched Volume 6 21.5% 23.4% -1.9% 21.5% 23.4% -1.9% 21.3% -2.1% 21.3% -2.1%
Nasdaq Listed (Tape C) Issues
Handled Volume 5 218 274 -20.3% 4,576 5,744 -20.3% 233 -22.5% 53,686 -22.9%
Matched Volume 6 195 236 -17.6% 4,088 4,963 -17.6% 201 -22.5% 46,250 -22.9%
Total Nasdaq Listed Consolidated Volume 1,769 1,857 -4.7% 37,152 38,997 -4.7% 1,754 -14.8% 403,392 -15.2%
Share of Total Consolidated Volume
Handled Volume 5 12.3% 14.7% -2.4% 12.3% 14.7% -2.4% 13.3% -1.3% 13.3% -1.3%
Matched Volume 6 11.0% 12.7% -1.7% 11.0% 12.7% -1.7% 11.5% -1.1% 11.5% -1.1%
Exchange-Traded Funds 5,7
Handled Volume 5 225 355 -36.6% 4,727 7,453 -36.6% 235 -36.1% 54,030 -36.4%
Matched Volume 6 209 320 -34.9% 4,381 6,728 -34.9% 212 -35.8% 48,824 -36.1%
Total ETF Consolidated Volume 987 1,400 -29.5% 20,728 29,409 -29.5% 1,028 -28.9% 236,429 -29.2%
Share of Total Consolidated Volume
Handled Volume 5 22.8% 25.3% -2.5% 22.8% 25.3% -2.5% 22.9% -2.6% 22.9% -2.6%
Matched Volume 6 21.1% 22.9% -1.8% 21.1% 22.9% -1.8% 20.7% -2.2% 20.7% -2.2%

1

Data includes currency products.

2

Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.

3

Includes trading in U.S. equity options contracts, not equity-index options.

4

Includes all volume executed in NYSE Group crossing sessions.

5

Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.

6

Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.

7

Data included in previously identified categories.

*

ADVs calculated with the appropriate number of NYSE Liffe U.S. trading days. Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.

Contacts:

NYSE Euronext
Media:
Amsterdam, +31.20.550.4488
or
Lisbon, +351.217.900.029
or
New York, +1.212.656.2411
or
Brussels, +32.2.509.1392
or
London, +44.20.7379.2789
or
Paris, +33.1.49.27.11.33
or
Investor Relations:
New York, +1.212.656.5700
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here